PML and breast carcinoma: The etiological involvement of PML in APL pathogenesis, its negative regulatory role on survival, and proliferation pathways (Salomoni et al., 2008) along with its downregulated expression in human cancers of multiple histological origins, including breast cancer (Gurrieri et al., 2004), provide strong evidence that PML acts as a tumor suppressor factor.